Deficit Reduction Act of 2005

Overview

The Deficit Reduction Act of 2005 (DRA) was created to cut Medicare spending and reduce reimbursement fraud. More recent provisions require that hospitals identify high-cost, high-volume healthcare-acquired conditions (HAC) that could have been prevented through the use of evidence-based guidelines. Often times, this means that hospitals are not paid for infections that could have been prevented.  

Many of these DRA-classified conditions are transmitted through surgical sites and medical devices, including catheters, ventilators, endoscopes and implants. In order to avoid non-payment, hospitals are looking to better protect surgical surfaces and devices against a broad spectrum of microorganisms.

Hospital and other healthcare facilities have turned to Agion-treated medical devices and surfaces to limit patient exposure to dangerous bacteria and, ultimately, reduce the number of preventable infections that not only impact quality care, but also a hospital’s bottom line.     

Products For Medical Applications

Anti-Microbial

Agion

Agion's antimicrobial technology keeps products clean and extends product lifespans using silver and copper. The technology behind Agion continuously resists microbe growth and provides products with built-in protection. Agion Antimicrobial can be applied to virtually any material or surface.